A potential complication of directional coronary atherectomy for in-stent restenosis.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
All current techniques for PTRA carry the risk of re-stenosis due to intimal hyperplasia and associated complications. More data are now available to better determine the best candidates for PTRA or surgical revascularization. Great progress has been made with the introduction of renal artery stenting. I believe that this technique, when adequately sized and positioned, will give the best long-term results. Further randomized trials are needed to prove that this technique is superior to PTRA.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In 11 female and 13 male patients 29 symptomatic femoropopliteal occlusions were treated with a novel intraluminal endarterectomy device (REDHA-CUT). The pre-existing stenoses (71 +/- 9%) could be reduced to 29 +/- 18% (means +/- s.d.). The arteriectomy procedure with this device took on average 5 +/- 3 min. Neither perforations nor dissections nor distal embolisms or any other complications were observed. In comparison with other percutaneous transluminal angioplasty procedures the clinical use of the novel REDHA-CUT device is safe, simple and fast and allows for the retrieval of plaque biopsies.